The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance
about
Testosterone deficiency in the aging maleInfluence of androgens on circulating adiponectin in male and female rodentsCare of the cancer survivor: metabolic syndrome after hormone-modifying therapy.The low density lipoprotein receptor modulates the effects of hypogonadism on diet-induced obesity and related metabolic perturbations.Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS).The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2.Testosterone levels and type 2 diabetes in men: current knowledge and clinical implications.Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study.Bioactive androgens and glucuronidated androgen metabolites are associated with subcutaneous and ectopic skeletal muscle adiposity among older black menThe evaluation of serum levels of testosterone in type 2 diabetic men and its relation with lipid profile.Andropause - state of the art 2015 and review of selected aspects.Androgens and adipose tissue in males: a complex and reciprocal interplay.Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review.Connecting the Lines between Hypogonadism and Atherosclerosis.Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy.Androgen Deficiency and Erectile Dysfunction in Patients with Type 2 Diabetes.Testosterone regulates bone response to inflammation.Advanced glycation end-products as markers of aging and longevity in the long-lived Ansell's mole-rat (Fukomys anselli)Do the interactions between glucocorticoids and sex hormones regulate the development of the metabolic syndrome?Dynamic alteration of serum testosterone with aging: a cross-sectional study from Shanghai, China.Diagnosis and management of testosterone deficiencyControversies in testosterone supplementation therapy.International spinal cord injury endocrine and metabolic extended data set.Basic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction.Androgens and male aging: Current evidence of safety and efficacy.Acute cardiac decompensation in a patient with beta-thalassemia and diabetes mellitus following cessation of chelation therapyMetabolic sequelae associated with androgen deprivation therapy for prostate cancer.Perpetuating effects of androgen deficiency on insulin resistanceMechanisms of obesity and related pathologies: androgen deficiency and endothelial dysfunction may be the link between obesity and erectile dysfunction.Hypogonadism and metabolic syndrome in nigerian male patients with both type 2 diabetes and hypertensionThe role of testosterone in type 2 diabetes and metabolic syndrome in men.Interaction of the endocrine system with inflammation: a function of energy and volume regulation.Aging men and lipids.Late onset hypogonadism, sexuality and fertility.Gender-based cardiometabolic risk evaluation in minority and non-minority men grading the evidence of non-traditional determinants of cardiovascular risk.Cardiovascular diseases and erectile dysfunction: the two faces of the coin of androgen deficiency.The paradox of low BNP levels in obesity.Testosterone replacement therapy in the setting of prostate cancer treated with radiation.Metabolic syndrome in patients with hematological diseases.Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease?
P2860
Q26770414-6584643E-29E6-4521-AE85-66CE5F8ED235Q27314775-50FA75C2-412E-4791-8755-8C81203B53C6Q33649441-70F8254C-48C3-43DD-A2B8-57A0F6E46FEFQ33825050-99092105-5B2B-45C7-A0C9-D3C6CD4A4D8DQ34063853-50CCB419-8B26-48DF-9ECA-68768FC5BA76Q34097510-0D45214F-E362-4971-98C5-9E9A07D6677EQ34398768-8E858440-A14F-4A60-9AB1-1D552076DE00Q34804834-EB8EA719-F177-4A6C-AAE5-0EA931B78BBBQ35019509-6C317AEF-16C1-47AA-A2E3-60A68292A1DEQ35139541-7C762AE5-415A-4EA4-ADA8-204DB86C8F78Q35632491-2E025C2E-D1F2-494D-BCC2-F1EF41119314Q35659922-8D09F84B-696D-45C1-BE9E-0BB0A36B4C2DQ35810322-EF1A080B-D1DB-40B9-BBC7-349C8052C798Q35810628-49EDDAC3-FB5F-4F2A-BAB6-0A18B31FBC4DQ35852422-6B3ACAFC-B19C-4948-B215-C4755791AE68Q35871552-1FC6AD01-0F35-40EE-8FEF-0A17E2DEE509Q35910549-94ED0533-4CAB-430C-8E92-78EDD59F7E57Q35947416-3764BA1F-5197-4EEA-B539-132AC4EF32B3Q35971236-AE24DB3F-FF47-411C-AF6A-B98868A494B1Q36108103-BCAC5FEC-38B2-499B-AB96-AD1B6D7C3AA9Q36293061-5AABCF6F-3C5E-4767-A18B-47200AFC1ABFQ36293076-1AF2762C-356D-43E7-820C-92750D15F06DQ36315948-D5816F1B-339F-455A-BFB8-765EC49DD79FQ36861695-F0CCE03B-72A4-4A7F-AE1C-58E7E442184CQ37084126-D74AACB0-A977-42BA-8B54-87E35D1C5D84Q37319367-CD810B88-3F0D-4E18-B173-4C41B410F65DQ37431937-27EB1A3D-9E5D-4481-BF0C-6D52228BEB27Q37478579-1CAFC122-7671-4C91-9611-B16A8FA95761Q37597592-2C785F0E-ECD0-4F49-BFA1-DD2E5209ADFFQ37671150-DF363661-9490-4250-A206-B00A3D328AC9Q37686143-797C4DDE-E883-437D-9DCA-27BBC9CB81CDQ37690138-C62BB24C-2C97-42E5-97BD-A6239CDD5419Q37756333-811AC358-BF92-49B3-BFA8-1ECFEE320648Q37789736-4A470D8F-5B2E-4409-AE80-046C5A4BE55FQ37825592-E4BF7078-2E01-4427-9C57-D6C805925183Q37827183-DCBF7DA2-10FD-4C96-A533-F3254E9E3393Q37869374-55A51704-C1D0-4122-A21E-B6F941668CAAQ38042783-890987F2-4D0B-4ECA-8FEA-98E3299E4586Q38044776-26C74BE9-6B47-40E3-AF77-FF59C95B6218Q38071012-C5CAB269-A3FC-40DB-B21A-0A8AC0378ADE
P2860
The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance
@ast
The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance
@en
The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance
@en-gb
The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance
@nl
type
label
The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance
@ast
The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance
@en
The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance
@en-gb
The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance
@nl
altLabel
The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance
@en
prefLabel
The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance
@ast
The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance
@en
The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance
@en-gb
The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance
@nl
P2093
P921
P3181
P1433
P1476
The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance
@en
P2093
P3181
P356
10.2164/JANDROL.108.005751
P407
P577
2008-08-21T00:00:00Z